Is ANI PHARMACEUTICALS INC (ANIP) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 37.1% / 30% | 17.7% / 30% | 16.9% / 30% | 3.92% / 5% | ✗ NOT HALAL |
| DJIM | 37.1% / 33% | 17.7% / 33% | 16.9% / 33% | 3.92% / 5% | ✗ NOT HALAL |
| MSCI | 42.8% / 33% | 20.5% / 33% | 19.5% / 33% | 3.92% / 5% | ✗ NOT HALAL |
| S&P | 37.1% / 33% | 17.7% / 33% | 16.9% / 33% | 3.92% / 5% | ✗ NOT HALAL |
| FTSE | 42.8% / 33% | 20.5% / 33% | 19.5% / 50% | 3.92% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 61.4% | |
| Operating Margin | 12.0% | |
| Net Margin | 8.9% | |
| Return on Equity (ROE) | 16.2% | |
| Return on Assets (ROA) | 3.8% |
Cash Flow & Balance Sheet
| Operating Cash Flow | $185M |
| Free Cash Flow | $151M |
| Total Debt | $617M |
| Debt-to-Equity | 116.2 |
| Current Ratio | 2.7 |
| Total Assets | $1.4B |
Price & Trading
| Last Close | $74.14 |
| 50-Day MA | $77.75 |
| 200-Day MA | $81.06 |
| Avg Volume | 440K |
| Beta | 0.5 |
|
52-Week Range
$56.71
| |
About ANI PHARMACEUTICALS INC (ANIP)
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is ANI PHARMACEUTICALS INC (ANIP) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), ANI PHARMACEUTICALS INC is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is ANI PHARMACEUTICALS INC's debt ratio?
ANI PHARMACEUTICALS INC's debt ratio is 37.1% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 42.8%.
What are ANI PHARMACEUTICALS INC's key financial metrics?
ANI PHARMACEUTICALS INC has a market capitalization of $1.6B, trailing P/E ratio of 21.9, and revenue of $883M. The company maintains a gross margin of 61.4% and a net margin of 8.9%. Return on equity stands at 16.2%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.